Lexaria Strengthens its International Patent Portfolio to 19 Patents Granted
New patent granted in India bolsters worldwide patent coverage, adding to existing patents in the EU, the U.S., and Australia
Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (CSE:LXX) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces further expansion of its intellectual property portfolio with its first-ever patent granted in India.